Circulating Concentrations of Adiponectin, an Endogenous Lipopolysaccharide Neutralizing Protein, Decrease in Rats with Polymicrobial Sepsis
- 31 August 2006
- journal article
- Published by Elsevier BV in Journal of Surgical Research
- Vol. 134 (2), 348-353
- https://doi.org/10.1016/j.jss.2006.01.001
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A PILOT-CONTROLLED STUDY OF A POLYMYXIN B-IMMOBILIZED HEMOPERFUSION CARTRIDGE IN PATIENTS WITH SEVERE SEPSIS SECONDARY TO INTRA-ABDOMINAL INFECTIONShock, 2005
- Intestinal permeability and systemic infections in critically ill patients: Effect of glutamine*Critical Care Medicine, 2005
- Novel Therapies for Sepsis: A ReviewJournal Of Trauma-Injury Infection and Critical Care, 2005
- Septic shockThe Lancet, 2005
- Adiponectin and Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- Diet-induced insulin resistance in mice lacking adiponectin/ACRP30Nature Medicine, 2002
- Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learnedCritical Care Medicine, 2001
- Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophagesBlood, 2000
- Analysis of an expression profile of genes in the human adipose tissueGene, 1997